Skip to content

A Specialized Diet for Multiple Sclerosis

A Flavonoid-enriched Mediterranean Diet for Multiple Sclerosis

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07033975
Acronym
FLAMEMS
Enrollment
100
Registered
2025-06-24
Start date
2023-04-04
Completion date
2028-12-31
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Sclerosis

Brief summary

This study examines the impact of a Mediterranean diet on individuals with multiple sclerosis (MS). MS is a multifactorial disease in which environmental factors, such as nutrition, can influence disease progression. Therefore, this study aims to investigate whether a healthier dietary pattern, specifically a flavonoid-rich Mediterranean diet, can affect disease parameters.

Interventions

OTHERFlavonoid-enriched Mediterranean Diet

A set of dietary guidelines describing an adjusted Mediterranean diet focusing on the intake of flavonoid-rich products.

Sponsors

Jerome J. A. Hendriks
Lead SponsorOTHER
Revalidatie & MS Centrum Overpelt
CollaboratorOTHER

Study design

Allocation
NA
Intervention model
SEQUENTIAL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
30 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Expanded Disability Status Scale (EDSS): 0-6

Exclusion criteria

* Diagnosed digestive pathology

Design outcomes

Primary

MeasureTime frameDescription
Microbiota changesThree timepoints, before start of the strict diet (day 14), after the strict diet (day 31), and after the follow-up period of three months (day 122).Microbiota sequencing on fecal samples to identify the different bacterial strains that are present.

Countries

Belgium

Contacts

Primary ContactJerome JA Hendriks, Professor
jerome.hendriks@uhasselt.be+3211269207

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026